Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4DCAF1

 Abstract

The mechanism by which the FERM domain protein Merlin, encoded by the tumor suppressor NF2, restrains cell proliferation is poorly understood. Prior studies have suggested that Merlin exerts its antimitogenic effect by interacting with multiple signaling proteins located at or close to the plasma membrane. We have recently observed that Merlin translocates into the nucleus and binds to and inhibits the E3 ubiquitin ligase CRL4DCAF1. Genetic evidence indicates that inactivation of Merlin induces oncogenic gene expression, hyperproliferation, and tumorigenicity by unleashing the activity of CRL4DCAF1. In addition to providing a potential explanation for the diverse effects that loss of Merlin exerts in multiple cell types, these findings suggest that compounds inhibiting CRL4DCAF1 may display therapeutic efficacy in Neurofibromatosis type 2 and other cancers driven by Merlin inactivation.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
4433 - 4436
doi
10.4161/cc.9.22.13838
Type
Extra Views
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4DCAF1